Inno Medicine Moves Novel Liposome Into Pivotal Trial For Coronary Plaque

 
• By Dexter Jie Yan
  
Inno Medicine's YN001 will directly tackle coronary atherosclerosis plaques with regression potential. (Shutterstock)

More from Interviews

More from Leadership